Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
20.98
+0.29 (1.40%)
Nov 20, 2024, 4:00 PM EST - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $314.73 million as of November 21, 2024. Its market cap has increased by 255.06% in one year.
Market Cap
314.73M
Enterprise Value
224.30M
1-Year Change
255.06%
Ranking
Category
Stock Price
$20.98
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has increased from $122.75M to $314.73M, an increase of 156.40%. That is a compound annual growth rate of 21.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 310.38M | 252.57% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
| Jan 10, 2020 | 122.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 309.93M |
| Sanara MedTech | 309.17M |
| Alpha Teknova | 303.29M |
| Immutep | 301.93M |
| uniQure | 301.23M |
| Kodiak Sciences | 297.16M |
| C4 Therapeutics | 296.47M |
| ClearPoint Neuro | 296.26M |